Application 219168
- Type
- ANDA
- Sponsor
- CAPLIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HALOPERIDOL DECANOATE | HALOPERIDOL DECANOATE | INJECTABLE;INJECTION | EQ 50MG BASE/ML | No | No |
| 002 | HALOPERIDOL DECANOATE | HALOPERIDOL DECANOATE | INJECTABLE;INJECTION | EQ 100MG BASE/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219168-001 | HALOPERIDOL DECANOATE | HALOPERIDOL DECANOATE | EQ 50MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | |
| A219168-002 | HALOPERIDOL DECANOATE | HALOPERIDOL DECANOATE | EQ 100MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219168-001 | AO |
| A219168-002 | AO |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219168-001 | HALOPERIDOL DECANOATE | EQ 50MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219168-002 | HALOPERIDOL DECANOATE | EQ 100MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219168-001 | HALOPERIDOL DECANOATE | EQ 50MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219168-002 | HALOPERIDOL DECANOATE | EQ 100MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219168-001 | HALOPERIDOL DECANOATE | EQ 50MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219168-002 | HALOPERIDOL DECANOATE | EQ 100MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219168-001 | HALOPERIDOL DECANOATE | EQ 50MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219168-002 | HALOPERIDOL DECANOATE | EQ 100MG BASE/ML | INJECTABLE / INJECTION | AO | 2025-05-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219168-001 | AO | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219168-002 | AO | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219168-001 | AO | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219168-002 | AO | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219168-001 | AO | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A219168-002 | AO | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219168-001 | AO | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219168-002 | AO | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Haloperidol Decanoate | HALOPERIDOL DECANOATE | Armas Pharmaceuticals Inc. | 80d51d2c-30e4-4eef-b184-0cebb30ca429 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 219168 ANDA219168 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE | Armas Pharmaceuticals Inc. | 9979e28f-2716-4788-8605-16f6edf158b5 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 219168 ANDA219168 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE | REMEDYREPACK INC. | 15b82169-882b-40ef-bbda-5adc3e7eb930 | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 219168 ANDA219168 |
| HALOPERIDOL DECANOATE | HALOPERIDOL DECANOATE | Somerset Therapeutics, LLC | 068fc913-779d-44c6-9585-3aa80e751bee | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 219168 ANDA219168 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE | Caplin Steriles Limited | 4f9af14a-38c4-4826-aca0-3501edb854e3 | 2025-05-26 | Boxed warning, Warnings, Adverse reactions | 219168 ANDA219168 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE | Armas Pharmaceuticals Inc. | f9876b88-3caa-4c08-9a59-9b4a455e101d | 2025-05-26 | Boxed warning, Warnings, Adverse reactions | 219168 ANDA219168 |